Ensuring that a world-leading pediatric research enterprise is positioned for ongoing growth and preeminence is a weighty task that demands an accomplished leader. In February 2016, Beverly Davidson, PhD, took on such a critical role as Chief Scientific Strategy Officer (CSSO) at Children’s Hospital of Philadelphia. In this newly created position, Dr. Davidson serves as an integral member of the CHOP Research Institute senior leadership team, has overall accountability for the implementation of the research strategic vision, oversees space and resources allocation, assists in recruitment of researchers, and works with development to ensure philanthropic support of CHOP’s research mission. She also has key role in coordinating scientific alignment of CHOP with the Perelman School of Medicine at the University of Pennsylvania.
Dr. Davidson remains the director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics. She holds the Arthur V. Meigs Chair in Pediatrics at CHOP, and is a professor in the department of Pathology and Laboratory Medicine at Penn Medicine. Her research is focused on inherited brain disorders and the development of novel therapies to treat these fatal diseases. She is a fellow of the American Association for the Advancement of Science and has served as co-chair for study sections and review committees for the National Institutes of Health and as a member of the national advisory council of the National Institute of Neurological Disorders and Stroke, among numerous other honors and leadership positions.
“Dr. Davidson brings to the CSSO position a wealth of scientific expertise, a stellar track record of scientific innovation and leadership, an exciting vision for CHOP research, and exceptional qualities as a mentor and role model,” said Bryan A. Wolf, MD, PhD, Chief Scientific Officer and director of the CHOP Research Institute, in appointing her to this new role.